Atopic dermatitis is a chronic inflammatory disease affecting 2 million people in France, including 850,000 children over the age of six. Among these patients, 33% find themselves in therapeutic limbo, convinced they have exhausted all treatment options without success. The daily burden of the disease is often underestimated, leading many to abandon their care journey. In response to this, Abbvie aims to redirect these patients and raise awareness about the availability of new treatment options, particularly in hospital settings.